Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
68,069,757
-
Share change
-
+2,636,048
-
Total reported value
-
$1,063,701,562
-
Put/Call ratio
-
77%
-
Price per share
-
$15.60
-
Number of holders
-
278
-
Value change
-
+$48,470,698
-
Number of buys
-
113
-
Number of sells
-
139
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q4 2022
As of 31 Dec 2022,
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by
278 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,069,757 shares.
The largest 10 holders included
MORGAN STANLEY, Mondrian Investment Partners LTD, Clal Insurance Enterprises Holdings Ltd, GOLDMAN SACHS GROUP INC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, MACQUARIE GROUP LTD, RENAISSANCE TECHNOLOGIES LLC, Point72 Asset Management, L.P., Capital Research Global Investors, and NORTHERN TRUST CORP.
This page lists
278
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.